EpoR stimulates rapid cycling and larger red cells during mouse and human erythropoiesis
dc.contributor.author | Hidalgo, Daniel | |
dc.contributor.author | Bejder, Jacob | |
dc.contributor.author | Pop, Ramona | |
dc.contributor.author | Gellatly, Kyle | |
dc.contributor.author | Hwang, Yung | |
dc.contributor.author | Maxwell Scalf, S | |
dc.contributor.author | Eastman, Anna E | |
dc.contributor.author | Chen, Jane-Jane | |
dc.contributor.author | Zhu, Lihua Julie | |
dc.contributor.author | Heuberger, Jules A A C | |
dc.contributor.author | Guo, Shangqin | |
dc.contributor.author | Koury, Mark J | |
dc.contributor.author | Nordsborg, Nikolai Baastrup | |
dc.contributor.author | Socolovsky, Merav | |
dc.date.accessioned | 2022-10-20T15:13:53Z | |
dc.date.available | 2022-10-20T15:13:53Z | |
dc.date.issued | 2021-12-17 | |
dc.identifier.citation | Hidalgo D, Bejder J, Pop R, Gellatly K, Hwang Y, Maxwell Scalf S, Eastman AE, Chen JJ, Zhu LJ, Heuberger JAAC, Guo S, Koury MJ, Nordsborg NB, Socolovsky M. EpoR stimulates rapid cycling and larger red cells during mouse and human erythropoiesis. Nat Commun. 2021 Dec 17;12(1):7334. doi: 10.1038/s41467-021-27562-4. PMID: 34921133; PMCID: PMC8683474. | en_US |
dc.identifier.eissn | 2041-1723 | |
dc.identifier.doi | 10.1038/s41467-021-27562-4 | en_US |
dc.identifier.pmid | 34921133 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/51182 | |
dc.description.abstract | The erythroid terminal differentiation program couples sequential cell divisions with progressive reductions in cell size. The erythropoietin receptor (EpoR) is essential for erythroblast survival, but its other functions are not well characterized. Here we use Epor-/- mouse erythroblasts endowed with survival signaling to identify novel non-redundant EpoR functions. We find that, paradoxically, EpoR signaling increases red cell size while also increasing the number and speed of erythroblast cell cycles. EpoR-regulation of cell size is independent of established red cell size regulation by iron. High erythropoietin (Epo) increases red cell size in wild-type mice and in human volunteers. The increase in mean corpuscular volume (MCV) outlasts the duration of Epo treatment and is not the result of increased reticulocyte number. Our work shows that EpoR signaling alters the relationship between cycling and cell size. Further, diagnostic interpretations of increased MCV should now include high Epo levels and hypoxic stress. | en_US |
dc.language.iso | en | en_US |
dc.relation | This article is based on a previously available preprint in bioRxiv, https://doi.org/10.1101/2020.11.30.404780. | |
dc.relation.ispartof | Nature Communications | en_US |
dc.relation.url | https://doi.org/10.1038/s41467-021-27562-4 | en_US |
dc.rights | Copyright © The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Cell division | en_US |
dc.subject | Cell growth | en_US |
dc.subject | Haematopoietic system | en_US |
dc.title | EpoR stimulates rapid cycling and larger red cells during mouse and human erythropoiesis | en_US |
dc.type | Journal Article | en_US |
dc.source.journaltitle | Nature communications | |
dc.source.volume | 12 | |
dc.source.issue | 1 | |
dc.source.beginpage | 7334 | |
dc.source.endpage | ||
dc.source.country | United States | |
dc.source.country | United States | |
dc.source.country | United States | |
dc.source.country | United States | |
dc.source.country | United States | |
dc.source.country | England | |
dc.identifier.journal | Nature communications | |
refterms.dateFOA | 2022-10-20T15:13:54Z | |
dc.contributor.department | Molecular, Cell and Cancer Biology | en_US |
dc.contributor.department | Morningside Graduate School of Biomedical Sciences | |
dc.description.thesisprogram | Bioinformatics and Computational Biology |